Search hospitals > Arizona > Phoenix
Barrow Neurological Institute
Claim this profilePhoenix, Arizona 85013
Global Leader in Multiple Sclerosis
Global Leader in Amyotrophic Lateral Sclerosis
Conducts research for Alzheimer's Disease
Conducts research for Motor Neuron Disease
Conducts research for Parkinson's Disease
160 reported clinical trials
16 medical researchers
Summary
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Motor Neuron Disease, Parkinson's Disease and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 153 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Margeaux E Snell, MD.Area of expertise
1Multiple Sclerosis
Global LeaderSOD1 negative
FUS negative
ATXN2 CAG/CAA repeat expansion positive
2Amyotrophic Lateral Sclerosis
Global LeaderSOD1 negative
FUS negative
ATXN2 CAG/CAA repeat expansion positive
Top PIs
Shafeeq S. LadhaBarrow Neurological Institute3 years of reported clinical research
Studies Motor Neuron Disease
Studies Amyotrophic Lateral Sclerosis
5 reported clinical trials
5 drugs studied
Anna BurkeBarrow Neurological Institute5 years of reported clinical research
Studies Alzheimer's Disease
Studies Down Syndrome
5 reported clinical trials
8 drugs studied
Holly Shill, MDBarrow Neurological Institute3 years of reported clinical research
Studies Parkinson's Disease
3 reported clinical trials
3 drugs studied
Margeaux E Snell, MDSt. Joseph's Hospital and Medical Center3 years of reported clinical research
Studies Cognitive Impairment
Studies Mild Cognitive Impairment
2 reported clinical trials
3 drugs studied
Clinical Trials running at Barrow Neurological Institute
Alzheimer's Disease
Parkinson's Disease
Dementia
Spinal Muscular Atrophy
Migraine
Epilepsy
Myasthenia Gravis
Multiple Sclerosis
Mild Cognitive Impairment
Muscular Atrophy
[18F]PI-2620 PET Imaging
for Alzheimer's Disease
This study is an open-label, multi-center, non-randomized pivotal Phase 3 study to assess the efficacy and safety of PET imaging with [18F]PI-2620 for detection of tau deposition in subjects with Alzheimer's disease (AD) and controls during lifetime when compared to histopathology obtained after death and completion of brain autopsy.
Recruiting2 awards Phase 3
Donanemab
for Alzheimer's Disease
This study is evaluating whether a drug called donanemab can slow the progression of Alzheimer's disease.
Recruiting1 award Phase 34 criteria
ACI-24.060
for Alzheimer's Disease and Down Syndrome
The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.
Recruiting0 awards Phase 1 & 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Barrow Neurological Institute?
Barrow Neurological Institute is a medical facility located in Phoenix, Arizona. This center is recognized for care of Multiple Sclerosis, Amyotrophic Lateral Sclerosis, Alzheimer's Disease, Motor Neuron Disease, Parkinson's Disease and other specialties. Barrow Neurological Institute is involved with conducting 160 clinical trials across 153 conditions. There are 16 research doctors associated with this hospital, such as Shafeeq S. Ladha, Anna Burke, Holly Shill, MD, and Margeaux E Snell, MD.